Solid third quarter results enabling the company to narrow it 2025 financial guidance rangeSponsor-enabled growth and repowerings for 2026/2027 COD on track with over 2 GW of projects now on identified opportunities listSigned binding 3rd party M&A agreement for operational solar portfolio Opportunistically raised $50MM of equity through equity issuance program PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) today reported third quarter 2025 financial results, ...

SPY003 was well tolerated and exhibited an ~85-day half-life, supporting potential quarterly or twice annual maintenance dosing SPY003 positive interim results unlock development of SPY130 (α4β7 + IL-23) and SPY230 (TL1A + IL-23) investigational combination therapies for IBD with potential for indication-leading efficacy, safety, and dosing profiles SPY003 expected to advance to the ongoing Part A of the SKYLINE Ph2 platform trial SKYLINE and SKYWAY trials are expected to provide 6 proof-of-concept readouts ...

EMERYVILLE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the third quarter of fiscal 2025 ended September 27, 2025. Highlights for Third Quarter Fiscal 2025 as compared to Third Quarter Fiscal 2024: Net sales increased by 5.4% to $1.17 billion.Comparable store sales increased by 1.2%.Gross margin was 30.4% compared to 31.1% last year.SG&A increased by 8.7% to $331.0 million.Operating ...

Data from Catalent’s preclinical studies evaluating certepetide as a SMARTag® ADC payload showed both improved tumor selective penetration and efficacy BASKING RIDGE, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today highlighted positive preclinical data as announced by Lisata’s licensing partner, Cata ...

Commercial execution delivers best quarter launch-to-date with growth across all dimensions of core business Raising OJEMDA full-year 2025 net product revenue guidance to $145 to $150 million Three-year FIREFLY-1 data to be released in oral presentation at Society for Neuro-Oncology on Nov. 23, 2025 Ended the third quarter with $451.6 million in cash, cash equivalents and short-term investments Company to host conference call and webcast today, November 4, 4:30 p.m. Eastern Time BRISBANE, Calif., Nov. 04, ...

SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company management team will participate in the following investor conferences in November: Stifel 2025 Healthcare Conference: Fireside chat on Tuesday, November 11, 2025 at 11:20 AM Eastern Time in New York, NY.Jefferies Global Healthcare Conference: Fireside chat on Monday, November 17, 2025 at 2:30 PM Greenwich Mean Time in London, England. Interested parties may ac ...

Third Quarter 2025 Revenues of $347.6 Million Reflect 26.0 Percent Growth and 23.7 Percent Organic Growth Over Third Quarter 2024 Revenues of $275.9 Million Unmanned Systems Third Quarter 2025 Revenues of $87.2 Million Reflect 35.8 Percent Organic Growth Over Third Quarter 2024 Revenues of $64.2 Million Kratos Government Solutions Third Quarter 2025 Revenues of $260.4 Million Reflect 20.0 Percent Organic Growth Over Third Quarter 2024 Revenues of $211.7 Million Third Quarter 2025 Consolidated Book to Bill R ...

Total contract valued at $100 million Lantana, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- JFB Construction Holdings (Nasdaq: JFB), a real estate development and construction company focused on hospitality, commercial, industrial, and residential property development, today announced that it has been approved for the issuance of an $18.9 million bond to act as general contractor for the first phase of construction of a public high school in DeSoto County, Fla. “Last month we announced that we executed an $18.9 ...

Continued Topline Momentum with Revenue of $65.7 million, Up Sequentially and Year-over-Year Gross Profit of $30.7 million, with Margin Expanding by 220 bps Sequentially and 125 bps Year-over-Year to 46.7% Ongoing Enhancements Across Grower-Processor Footprint Driving Stronger Sales, Profitability, and Margin Performance BOCA RATON, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is ple ...

MCLEAN, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today announced it sold via auction 25 deeply delinquent non-performing residential first lien loans (NPLs) from its mortgage-related investments portfolio to Revolve Capital LLC. The loans, with a balance of approximately $4.9 million, are currently serviced by Select Portfolio Servicing, Inc. The sale is part of Freddie Mac’s Extended Timeline Pool Offering (EXPO®) and the transaction is expected to settle in December 2025. Freddie M ...